BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15339695)

  • 1. Two clonal occurrences of tetrasomy 21 in an atypical chronic myeloid leukemia with wild-type RUNX1 alleles. Additional support for a gene dosage effect of chromosome 21 or RUNX1 in leukemia.
    Escher R; Mühlematter D; Scott HS; Jotterand M; Tobler A
    Haematologica; 2004 Aug; 89(8):ECR26. PubMed ID: 15339695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
    Deluche L; Joha S; Corm S; Daudignon A; Geffroy S; Quief S; Villenet C; Kerckaert JP; Laï JL; Preudhomme C; Roche-Lestienne C
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1110-7. PubMed ID: 18767145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
    Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
    Moosavi SA; Sanchez J; Adeyinka A
    Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duplication of isodicentric chromosome 21, idic(21)(p11.2), leading to pentasomy 21q in acute myeloid leukemia with multilineage dysplasia.
    Shimoyama M; Yamamoto K; Nishikawa S; Minagawa K; Katayama Y; Matsui T
    Cancer Genet Cytogenet; 2009 Oct; 194(1):38-43. PubMed ID: 19737652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment.
    Miething C; Grundler R; Mugler C; Brero S; Hoepfl J; Geigl J; Speicher MR; Ottmann O; Peschel C; Duyster J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4594-9. PubMed ID: 17360569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
    Sakai I; Tamura T; Narumi H; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
    Schafhausen P; Dierlamm J; Bokemeyer C; Bruemmendorf TH; Bacher U; Zander AR; Schnittger S; Hochhaus A
    Cancer Genet Cytogenet; 2009 Feb; 189(1):63-7. PubMed ID: 19167615
    [No Abstract]   [Full Text] [Related]  

  • 10. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
    Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
    Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1 DNA-binding mutants, associated with minimally differentiated acute myelogenous leukemia, disrupt myeloid differentiation.
    Cammenga J; Niebuhr B; Horn S; Bergholz U; Putz G; Buchholz F; Löhler J; Stocking C
    Cancer Res; 2007 Jan; 67(2):537-45. PubMed ID: 17234761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
    De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Morel F; Férec C; De Braekeleer M
    Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome.
    Agerstam H; Lilljebjörn H; Lassen C; Swedin A; Richter J; Vandenberghe P; Johansson B; Fioretos T
    Genes Chromosomes Cancer; 2007 Jul; 46(7):635-43. PubMed ID: 17394134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
    Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
    Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clonal anomalies involving RUNX1 in acute myeloid leukemia at diagnosis and after bone marrow transplantation.
    De Braekeleer E; Douet-Guilbert N; Basinko A; Le Bris MJ; Morel F; Berthou C; Férec C; De Braekeleer M
    Ann Hematol; 2010 Dec; 89(12):1277-81. PubMed ID: 20352434
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies.
    Kirito K; Sakoe K; Shinoda D; Takiyama Y; Kaushansky K; Komatsu N
    Haematologica; 2008 Jan; 93(1):155-6. PubMed ID: 18166807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.
    Yamashita N; Osato M; Huang L; Yanagida M; Kogan SC; Iwasaki M; Nakamura T; Shigesada K; Asou N; Ito Y
    Br J Haematol; 2005 Nov; 131(4):495-507. PubMed ID: 16281942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.